Identify the genetic basis of myopathies
Subgroup Leader : Valérie BIANCALANA
We study rare and severe neuromuscular disorders caused by mutations in proteins controlling intracellular organization and dynamics. We aim to tackle the three main bottlenecks in this field:
.jpg)
Identify the genetic basis of myopathies, myalgia and high athletic performances
Project leaders : Valérie BIANCALANA, Johann BOHM, Jocelyn LAPORTE
Understand and cure myotubular/centronuclear myopathies through gene modulation and pharmacology
Project leader : Jocelyn LAPORTE
Understand and cure tubular aggregates myopathy and Stormorken syndrome through gene modulation and pharmacology
Project leader : Johann BOHM
Subgroup Leader : Valérie BIANCALANA
Subgroup Leader : Jocelyn LAPORTE
Article in a journal
eLife ; Volume: 13 ; Page: RP95397
Article in a journal
Genome Medicine ; Volume: 16 ; Page: 87
Article in a journal
Trends in Molecular Medicine ; Volume: 30 ; Page: 579-591
Article in a journal
Communications Biology ; Volume: 7 ; Page: 549
Article in a journal
Skeletal Muscle ; Volume: 14
Article in a journal
Journal of Neurology
Article in a journal
Nature Genetics ; Volume: 56 ; Page: 395-407
Article in a journal
Médecine/Sciences ; Volume: 40 ; Page: 133-136
Article in a journal
Scientific Reports ; Volume: 14 ; Page: 445
Article in a journal
Journal of Neuromuscular Diseases ; Volume: 11
Current fundings:

Her work, supervised by Dr. Jocelyn Laporte, is entitled "New Therapeutic Approaches for Neuromuscular Diseases."
Read more
Follow our publications and latest research on Researchgate : www.researchgate.net/profile/Jocelyn-Laporte
Raw data for our study on Multi-omics comparisons of different forms of centronuclear myopathies and the effects of several therapeutic strategies. Mol Ther. 2021 Apr 30:S1525-0016(21)00247-1.
www.ncbi.nlm.nih.gov/geo/query/acc.cgi
www.sciencedirect.com/science/article/abs/pii/S1525001621002471
In the press: